InvestorsHub Logo
Followers 1
Posts 186
Boards Moderated 0
Alias Born 05/08/2017

Re: Ricky241025 post# 8430

Tuesday, 05/09/2017 11:06:22 PM

Tuesday, May 09, 2017 11:06:22 PM

Post# of 12606
$3 a share, I'd be ecstatic with $2 a share. Vivatrol which is produced by Alkermes (ALKS) generates 30% of the total revenue for Alkermes. Imagine when BICX101 the injectable is approved. It will force Alkermes into action to buy-out, or another company to do so.

BioCorRx is definitely a long play. I'd estimate 1-2 years from now at most.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BICX News